The global nitric oxide market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of the market can be attributed to factors such as increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, increasing number of patients with respiratory diseases, and growing demand for nitric oxide in healthcare facilities.
The global nitric oxide market is segmented on the basis of type into 99.92% purity and 99.99% purity; on the basis of application into hospitals and healthcare centers; and on the basis of region into North America, Latin America, Europe, Asia Pacific, Middle East & Africa (MEA). The North American region accounted for a major share in terms of revenue in 2017 owing to high adoption rates among hospitals in this region. However, Asia Pacific is expected to witness significant growth during the forecast period due to rising awareness about COPD among people living there coupled with increased government initiatives for improving healthcare infrastructure across countries such as India and China which will lead to an increase in demand for nitric oxide products over time.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of cardiovascular diseases and rising demand for pharmaceuticals are some of the factors driving the growth of this market.
- Increasing awareness about nitric oxide therapy and its benefits among patients is also driving the growth of this market.
- Lack of awareness about nitric oxide therapy among physicians, high cost associated with treatment, and lack of reimbursement policies are some factors that may hamper the growth rate in this market.
Industry Growth Insights published a new data on “Pharma-Grade Nitric Oxide Market”. The research report is titled “Pharma-Grade Nitric Oxide Market research by Types (99.92% Purity, 99.99% Purity), By Applications (Hospitals, Healthcare Centers), By Players/Companies Inomax, Praxair, Air Liquide, Novoteris”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharma-Grade Nitric Oxide Market Research Report
By Type
99.92% Purity, 99.99% Purity
By Application
Hospitals, Healthcare Centers
By Companies
Inomax, Praxair, Air Liquide, Novoteris
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Pharma-Grade Nitric Oxide Market Report Segments:
The global Pharma-Grade Nitric Oxide market is segmented on the basis of:
Types
99.92% Purity, 99.99% Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Healthcare Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Inomax
- Praxair
- Air Liquide
- Novoteris
Highlights of The Pharma-Grade Nitric Oxide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99.92% Purity
- 99.99% Purity
- By Application:
- Hospitals
- Healthcare Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharma-Grade Nitric Oxide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharma-grade nitric oxide is a purified, concentrated form of nitric oxide that has been specifically manufactured for use in medical treatments. It is often used to improve blood flow and oxygenation in the body, as well as to reduce inflammation.
Some of the major companies in the pharma-grade nitric oxide market are Inomax, Praxair, Air Liquide, Novoteris.
The pharma-grade nitric oxide market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharma-Grade Nitric Oxide Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharma-Grade Nitric Oxide Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharma-Grade Nitric Oxide Market - Supply Chain
4.5. Global Pharma-Grade Nitric Oxide Market Forecast
4.5.1. Pharma-Grade Nitric Oxide Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharma-Grade Nitric Oxide Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharma-Grade Nitric Oxide Market Absolute $ Opportunity
5. Global Pharma-Grade Nitric Oxide Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
5.3.1. 99.92% Purity
5.3.2. 99.99% Purity
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharma-Grade Nitric Oxide Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Healthcare Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharma-Grade Nitric Oxide Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharma-Grade Nitric Oxide Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharma-Grade Nitric Oxide Demand Share Forecast, 2019-2026
9. North America Pharma-Grade Nitric Oxide Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Healthcare Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
9.7.1. 99.92% Purity
9.7.2. 99.99% Purity
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharma-Grade Nitric Oxide Demand Share Forecast, 2019-2026
10. Latin America Pharma-Grade Nitric Oxide Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Healthcare Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
10.7.1. 99.92% Purity
10.7.2. 99.99% Purity
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharma-Grade Nitric Oxide Demand Share Forecast, 2019-2026
11. Europe Pharma-Grade Nitric Oxide Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Healthcare Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
11.7.1. 99.92% Purity
11.7.2. 99.99% Purity
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Groth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharma-Grade Nitric Oxide Demand Share, 2019-2026
12. Asia Pacific Pharma-Grade Nitric Oxide Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Healthcare Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
12.7.1. 99.92% Purity
12.7.2. 99.99% Purity
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharma-Grade Nitric Oxide Demand Share, 2019-2026
13. Middle East & Africa Pharma-Grade Nitric Oxide Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Healthcare Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharma-Grade Nitric Oxide Market Size and Volume Forecast by Type
13.7.1. 99.92% Purity
13.7.2. 99.99% Purity
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharma-Grade Nitric Oxide Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharma-Grade Nitric Oxide Market: Market Share Analysis
14.2. Pharma-Grade Nitric Oxide Distributors and Customers
14.3. Pharma-Grade Nitric Oxide Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Inomax
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Praxair
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Air Liquide
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novoteris
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
